BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 7, 2000
View Archived Issues
Merck returns alpha-adrenergic technology rights to Synaptic
Read More
Squalamine enters combination trials with cisplatin for advanced cancer
Read More
Novo Nordisk and Schering-Plough conclude diabetes copromotion agreement
Read More
Structure elucidation, biological activity of a novel antimitotic agent: FR-182877
Read More
Potent histamine H3 receptor ligands designed at Sanofi-Synthelabo
Read More
New Lilly compounds potentiate glutamate receptor function
Read More
Macrophage scavenger receptor antagonists under study at SB
Read More
Modulators of CCR5 receptor and their use presented by SmithKline Beecham
Read More
New epipodophyllotoxin anticancer agent reported; studies on mechanism of action described
Read More
Daiichi claims pyrazole derivatives as antitumor agents
Read More
N-type calcium channel antagonists in early development at Ono
Read More
Aventis responds to the need for new antibiotics: first regulatory filing for the ketolide class
Read More
European mutual recognition approval obtained for candesartan/HCTZ combination
Read More
Ilex Oncology acquires U.S. operations of British Biotech
Read More
Patent covering novel HCV discovery issued to Chiron
Read More
Tyrosine kinase inhibitor D-58 is a potent antiallergic, antiinflammatory agent
Read More
AAAAI news: BM-144 as a new lead TxA2 antagonist molecule for asthma, thrombosis
Read More
DP-b99 enters phase I testing in Germany
Read More
Peptidomimetic VLA-4 antagonists: promising early results presented at AAAAI meeting
Read More
Amerimmune's phase I/II trial of Cytolin now formally under way
Read More
Elan to enter the oncology market by acquiring The Liposome Company
Read More
Heparinase-inhibitory fungal metabolites discovered by Korean/Japanese research team
Read More
Aerosol route preferred for measles vaccination campaign
Read More
New use patents expand coverage for Aradigm's pulmonary drug delivery system
Read More
Use of secretin for autism receives broad patent coverage
Read More
Gelkem and Ethypharm to jointly develop controlled-release drugs
Read More
Thalamic stimulation provides benefits over thalamotomy for severe tremor
Read More